An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer

J. Rubin, D. A. Decker, D. L. Ahmann, R. T. Eagan, J. N. Ingle, R. G. Hahn

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

A phase II study utilizing VP-16 and adriamycin in a randomized fashion tested the concept of synchronization of the drugs in treatment of metastatic breast cancer. Although there was a trend in median survival following the synchronized schedule, there was no significant difference in survival or progression-free intervals. The concept of synchronization was not established.

Original languageEnglish (US)
Pages (from-to)149-151
Number of pages3
JournalOncology
Volume37
Issue number3
DOIs
StatePublished - Jan 1 1980

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Rubin, J., Decker, D. A., Ahmann, D. L., Eagan, R. T., Ingle, J. N., & Hahn, R. G. (1980). An evaluation of two schedules of VP-16 and adriamycin in patients with advanced breast cancer. Oncology, 37(3), 149-151. https://doi.org/10.1159/000225424